Research Archive — Page 128 of 194
-
April 15, 2015
VU team’s cattle research may yield lung disease clues
Vanderbilt University researchers have found a genetic mutation that causes pulmonary hypertension in cattle grazed at high altitude, and which leads to a life-threatening condition called brisket disease. -
April 13, 2015
Vanderbilt study finds babies exposed to narcotic pain relievers more likely to experience drug withdrawal syndrome
Legally prescribed narcotics taken during pregnancy can lead to neonatal abstinence syndrome, especially in combination with tobacco or SSRIs. -
April 9, 2015
VUSM student lands fellowship to study ethics and discipline
Kelly Wolenberg, a third-year medical student at the Vanderbilt University School of Medicine, has been named to take part in the 2015 Fellowships at Auschwitz for the Study of Professional Ethics (FASPE). -
April 8, 2015
VU joins national effort to speed Ebola therapy testing
Vanderbilt University researchers have joined a multi-center effort led by Pennsylvania-based Inovio Pharmaceuticals Inc. to accelerate development of potential antibody therapies against the often-lethal Ebola virus. -
April 8, 2015
Micelle “packets” deliver cancer drugs
Vanderbilt researchers designed micelle “packets” to selectively deliver anti-cancer drugs to breast cancer cells. -
April 6, 2015
New player in heart cell growth
Vanderbilt researchers have identified a new protein involved in heart cell growth, which could improve understanding of pathologic cardiac hypertrophy. -
April 3, 2015
Cancer signaling pathway blocker
Researchers at Vanderbilt University have discovered a new way to inhibit Hedgehog (Hh) signaling, an important regulatory pathway for vertebrate development – and cancer.